Small Molecule of the Year – 2022
Drug Hunter
APRIL 20, 2023
We asked the global drug discovery community to nominate and vote on their favorite molecule from 2022, and the results are in. The Vote and Runners-Up #1: Deucravacitinib (Bristol Myers Squibb, 24%) Deucravacitinib stands out even with an impressive cohort of competitive nominees for 2022, with the runners-up shown below. #2:
Let's personalize your content